1 / 16

Professor Sergey V. Yakovlev, MD, PhD 1 st Moscow State Med. Univ., Moscow, Russia

54 th ICAAC, Washington, DC, 09/06/2014 Slide Session 056: Novel Infection Control Observations. Multicentre Study of the Prevalence and Clinical Value of Hospital-Acquired Infections in Emergency Hospitals of Russia (ERGINI Study) [K-574]. Professor Sergey V. Yakovlev, MD, PhD

farrism
Télécharger la présentation

Professor Sergey V. Yakovlev, MD, PhD 1 st Moscow State Med. Univ., Moscow, Russia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 54th ICAAC, Washington, DC, 09/06/2014 Slide Session 056: Novel Infection Control Observations Multicentre Study of the Prevalence and Clinical Value of Hospital-Acquired Infections in Emergency Hospitals of Russia (ERGINI Study) [K-574] Professor Sergey V. Yakovlev, MD, PhD 1st Moscow State Med. Univ., Moscow, Russia Co-authors: Prof. V.B.Beloborodov, Dr. M.P.Suvorova, Prof. V.A.Rudnov, Dr. A.A.Rog, and ERGINI Study Group

  2. Disclosures • Consultancy, lecturing • Astellas, AstraZeneca, MSD, Novartis, Pfizer • Advisory Boards • Pfizer, R-farm • Research Grants • Pfizer

  3. Hospital-acquired infections: a major public health threat in XXI century • Increased morbidity due to objectives reasons1 • Increased mortality2 • Increased in-hospital stay and costs3 • Limited treatment options due to high prevalence of MDR nosocomial pathogens 1 Carlet J, e.a. CID 2009;49:747-9 2 Klevens RM, e.a. Public Health Report 2007;122:160-6 3 Stone PW, e.a. Am J Infect Contr 2005;33:542-7

  4. Background • The methodical state system of surveillance of HAI is not available in Russia • The registration and reporting of HAI in the majority of cases is not mandatory • About 30,000 cases of HAI recorded in annual reports of state epidemiological service are seemed to be badly underestimated • The prevalence data on HAIs outside the ICU is not available heretofore

  5. The Aim of the ERGINI Study • To study the prevalence, epidemiological and microbiological characteristics, clinical value and outcomes of HAI in 5 different units of emergency multifields hospitals in Russia

  6. ERGINI Study design • Prospective • Multicentre • 1-day prevalence study with 28-days follow-up • 32 emergency hospitals from18 cities of RF • 1 day of investigation in each study unit: • ICU, Therapeutic, General Surgery, Urology, Neurology • Schedule time: January – May 2013

  7. Methods Including criteria • All patients treated in medical unit on the day of study were included HAIs detection • Careful inspection of case reports • Examination of clinical and laboratory data for the presence of HAI according to CDC criteria

  8. Patients • Totally 3809 pts were included in the study during 5 days of investigation ICU Therapy Surgery Urology Neurology 449 1281 1431 342 306 • Number of patients with • No infection 2432 • Community-acquired infection 1087 • Hospital-acquired infection 290

  9. ERGINI Study: main results Prevalence of HAIs: 7.61% (95%CI 6.81%, 8.50%) ICUNeurologyTherapySurgeryUrology 27.6% 13.7% 4.7% 3.8% 3.8% Clinical relevanceHAI+No HAI Mortality, % 16.5 3.0 Length of hospital stay, days 24.6±11.4 16.2±15.3 The estimated annual number of HAIs in Russia ≈ 2,300,000 cases

  10. Severity of infection Infection Grade Hospital-acquired Community-acquired Sepsis 55.6% 80.4% Severe sepsis 36.1% 16.7% Septic shock 8.3% 2.9%

  11. HAIs: epidemiology & microbiology Infection sitePredominant pathogens Lower RTI 39.6% Klebsiella spp. 19,6% UTI 16.7% Escherichia coli 12,2% SSTI 14.3% Staphylococcus aureus 11,2% IAI 9.9% Acinetobacter spp. 10,9% Clinical sepsis 9.9%Candida spp. 8,3%

  12. ERGINI Study: the prevalence of resistant nosocomial Gram+ pathogens % 69 49 17 2

  13. ERGINI Study: the prevalence of resistant nosocomial Gram- pathogens % 95 79 74 61 41

  14. Conclusion • The prevalence of hospital-acquired infections in Russian emergency multifields hospitals is high • These infections make a strong impact on the length of hospital stay and hospital mortality • The difficulties of HAI’s antimicrobial treatment are associated with significant prevalence of cephalosporin- and carbapenem-resistant Gram-negative pathogens

  15. Limitation of the study • We can’t exactly extrapolate these findings to the all types of hospitals like tertialy hospital and special-purpose institutions (oncologic, hematologic, transplantologist)

  16. Acknowledgment Participants of the investigation – ERGINI Study Group • Moscow: Suvorova M, Beloborodov V, Kameneva T, Rog A, Berdnikova N, Tokareva I, Nikiforova S, Molostova T, Erofeeva S, Meleshina Y, Anderzhanova A, Novozhilova E, Shalyapina O, Gavrilov M, Dmitrieva I. • S-Petersburg: Shlyapnikov S, Naser N. • Krasnodar: Basin E. • Volgograd: Barkanova O. • Samara: Petrovskaya Y. • Ulyanovsk: Kovelenov S. • Tolyatti: Nikolaeva T. • Surgut: Trapeznikova B. • Barnaul: Ovtchinnikova O. • Yaroslavl: Paliutin S. • Voronezh: Kotelnikova T. • Ekaterinburg: Bagin V, Rudnov V. • Ufa: Abubakirova A, Zolotuchin K. • Chelyabinsk: Pribytkova O. • Yakutsk: Portnyagina U. • Ulan-Ude: Danchinova A. • Vologda: Grishina N. • Vladivostok: Eliseeva E. Statistics: Rebrova O.

More Related